Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors-Reference-Cited by-同舟云学术

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors

Published:2010-03-18 Issue:7 Volume:17 Page:892-904
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Pesonen S,Nokisalmi P,Escutenaire S,Särkioja M,Raki M,Cerullo V,Kangasniemi L,Laasonen L,Ribacka C,Guse K,Haavisto E,Oksanen M,Rajecki M,Helminen A,Ristimäki A,Karioja-Kallio A,Karli E,Kantola T,Bauerschmitz G,Kanerva A,Joensuu T,Hemminki A

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201017.pdf

Reference56 articles.

1. Alemany R . Cancer selective adenoviruses. Mol Aspects Med 2007; 28: 42–58.

2. Stone D, Lieber A . New serotypes of adenoviral vectors. Curr Opin Mol Ther 2006; 8: 423–431.

3. Lin E, Nemunaitis J . Oncolytic viral therapies. Cancer Gene Therapy 2004; 11: 643–664.

4. Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE . Oncolytic viruses in cancer therapy. Cancer Lett 2007; 254: 178–216.

5. Alemany R, Cascallo M . Oncolytic viruses from the perspective of the immune system. Future Microbiol 2009; 4: 527–536.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 Vectors;Genes;2022-11-07

2. Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19;SN Comprehensive Clinical Medicine;2021-06-22

3. Viral vector platforms within the gene therapy landscape;Signal Transduction and Targeted Therapy;2021-02-08

4. Development of a New Hyaluronic Acid Based Redox-Responsive Nanohydrogel for the Encapsulation of Oncolytic Viruses for Cancer Immunotherapy;Nanomaterials;2021-01-08

5. Modulation of the tumor microenvironment with an oncolytic adenovirus for effective T-cell therapy and checkpoint inhibition;Methods in Enzymology;2020